On 23 May, Parkway Medical Services (PMS) Hong Kong and Caritas – Hong Kong signed an MOU to redevelop Precious Blood Hospital. This partnership is set to elevate healthcare quality and service excellence for more people in the city.
The project includes renovating the current hospital, upgrading its facilities, setting up an off-site ambulatory care centre, and developing a new ambulatory clinical block.
This new block will feature a state-of-the-art medical centre for day surgeries and specialised treatments in ophthalmology, otolaryngology, and orthopaedic surgeries. Patients can look forward to a revitalised hospital that will focus on outpatient consultation, elderly healthcare, and high-volume day procedures.
PMS, a collaboration between IHH and NWS Holdings, also operates our ambulatory care centres/ clinics, diagnostic lab unit, and external collaboration projects in Hong Kong.
Leveraging its extensive hospital development expertise, this partnership with Caritas will meet the healthcare needs of patients in the neighbourhood and beyond, reinforcing our aspiration to #CareForGood.
Related Stories
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
Parkway Shanghai Opens International Centre for Hepatobiliary and Pancreatic Diseases
Mount Elizabeth Hospitals Celebrate 97 Wins at Singapore Health Quality Service Awards 2026
Gleneagles Hospital Johor Opens International Lounge to Enhance Cross-border Care
Fortis Memorial Research Institute Gives Heart Patient a New Lease of Life
Gleneagles Hospital, Mumbai Successfully Treats India’s Youngest POEM Patient
Our team helped an underweight 14-month-old child with a rare swallowing disorder restore the ability to eat and gain weight normally through the minimally invasive procedure.
